Bonus BioGroup Ltd. (TLV:BONS)
Israel · Delayed Price · Currency is ILS · Price in ILA 19.40
-0.50 (-2.51%)
Sep 17, 2026, 5:24 PM IDT
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 232.46 million as of September 18, 2026. Its market cap has decreased by -8.70% in one year.
Market Cap
232.46M
Enterprise Value
240.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
19.40
ChartMarket Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 232.46M, an increase of 1,780.34%. That is a compound annual growth rate of 23.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 232.46M | -20.70% |
| Dec 31, 2025 | 293.15M | 110.92% |
| Dec 31, 2024 | 138.98M | -28.74% |
| Dec 31, 2023 | 195.04M | -13.02% |
| Dec 29, 2022 | 224.24M | -84.58% |
| Dec 30, 2021 | 1.45B | 200.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Matricelf | 79.94M |
| Clal Biotechnology Industries | 38.11M |
| BioLineRx | 34.07M |
| Purple Biotech | 32.42M |
| BioLight Life Sciences | 26.58M |
| Evogene | 24.33M |
| XTL Biopharmaceuticals | 23.84M |
| Can-Fite BioPharma | 14.99M |